Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.

Authors:
  • GDGeorge DeMaagd
    George DeMaagd
  • APAshok Philip
    Ashok Philip

Abstract
This installment of a five-part series reviews the role of nondopaminergic pharmacotherapies and adjunctive options-such as monoamine oxidase type B inhibitors, catechol-O-methyltransferase inhibitors, and anticholinergic agents-in managing Parkinson's disease. Nonpharmacological treatments are also explored.

This publication has 123 references indexed in Scilit: